Assembly Biosciences

Youtube Subscribe

Open: 0.81 Close: 0.82 Change: 0.01

How to get informed about Assembly Biosciences Company Inc quickly using an AI.

This document will help you to evaluate Assembly Biosciences without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Assembly Biosciences are: Assembly, Biosciences, Inc, ASMB, Volatility, Hits, Heres, …

Concept Map

Semantic Network

Stock Summary

Assembly Biosciences, Inc. discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's next-generation HBV core inhibitors include ABI-4334,.

Today's Summary

Assembly Biosciences Inc (ASMB) Volatility Hits 8.45% – Heres what an investor can do – stocks register. Analysts forecast that Assembly Biosciences will post -1.15 EPS for the current year. Gilead Sciences wants first dibs on all Assembly Biobsciences programs. The biopharmaceutical company discovers and develops therapeutic candidates.

Today's News

Assembly Biosciences Inc (ASMB) Volatility Hits 8.45% – Heres what an investor can do – stocks register. Analysts forecast that Assembly Biosciences will post -1.15 EPS for the current year. Gilead Sciences wants first dibs on all Assembly Biobsciences programs. The biopharmaceutical company discovers and develops therapeutic candidates.

Stock Profile

"Assembly Biosciences, Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's next-generation HBV core inhibitors include ABI-4334, which is in Phase 1a studies for the treatment of HBV; and ABI-H3733, which is in Phase 1b clinical study. It is also involved in novel small molecule approaches for HBV and hepatitis delta virus (HDV) comprising an orally bioavailable HBV/HDV entry inhibitor and liver-focused interferon-a receptor agonist. In addition, the company develops Herpesvirus programs, such as ABI-5366 HSV-2, a long-acting helicase inhibitor; and pan-herpes non-nucleoside polymerase inhibitors for transplant-associated infections. Further, Assembly Biosciences, Inc. has collaboration agreement with BeiGene, Ltd. to develop and commercialize the novel core inhibitor product candidates for chronic HBV infection in the People's Republic of China, Hong Kong, Taiwan, and Macau; and clinical trial collaboration agreement with Arbutus Biopharma Corporation to conduct a randomized, multi-center, and open-label clinical trials, as well as agreement with Antios Therapeutics, Inc. for triple combination therapy. The company also has license agreement with Indiana University Research and Technology Corporation for HBV research. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California."

Keywords

Are looking for the most relevant information about Assembly Biosciences? Investor spend a lot of time searching for information to make investment decisions in Assembly Biosciences. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Assembly Biosciences are: Assembly, Biosciences, Inc, ASMB, Volatility, Hits, Heres, and the most common words in the summary are: assembly, bioscience, inc, news, gilead, bio, biosciences, . One of the sentences in the summary was: Assembly Biosciences Inc (ASMB) Volatility Hits 8.45% – Heres what an investor can do – stocks register. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #assembly #bioscience #inc #news #gilead #bio #biosciences.

Read more →

Youtube Subscribe

---